By Dylan Bushell-Embling, Australian Life Scientist
Anatara Lifesciences used this week’s BIO International Convention to pursue distribution and development partners for Detach, its new non-antibiotic treatment for diarrhoea.
The company is pursuing commercialisation for the product in pigs first and subsequently plans to expand its use to other livestock and develop the treatment for use in humans.
Detach works by stopping bacteria from attaching to the lining of the intestine, as well as blocking the action of their toxins.
Anatara CEO Dr David Venables said there is a strong market opportunity for Detach in light of growing consumer demand for antibiotic-free food and concerns over antibiotic-resistant “superbugs”.
“The World Health Organization has warned that antimicrobial resistance is a significant looming threat to human health and authorities are now moving to tackle the issue by limiting the use of antibiotics in animal agriculture,” he said.
The article can be found here.